CN106858249A - A kind of health beverages of reduction blood fat and blood viscosity - Google Patents
A kind of health beverages of reduction blood fat and blood viscosity Download PDFInfo
- Publication number
- CN106858249A CN106858249A CN201710257896.5A CN201710257896A CN106858249A CN 106858249 A CN106858249 A CN 106858249A CN 201710257896 A CN201710257896 A CN 201710257896A CN 106858249 A CN106858249 A CN 106858249A
- Authority
- CN
- China
- Prior art keywords
- health beverages
- lotus leaf
- blood
- health
- hawthorn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 77
- 239000008280 blood Substances 0.000 title claims abstract description 77
- 230000036541 health Effects 0.000 title claims abstract description 66
- 235000013361 beverage Nutrition 0.000 title claims abstract description 58
- 230000009467 reduction Effects 0.000 title claims abstract description 26
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 37
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 37
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 36
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 30
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 30
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 30
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 30
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 30
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 30
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 30
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 30
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 30
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 30
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000008187 granular material Substances 0.000 claims abstract description 5
- 244000269722 Thea sinensis Species 0.000 claims abstract 10
- 241001092040 Crataegus Species 0.000 claims description 29
- 239000000706 filtrate Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims 2
- 230000003276 anti-hypertensive effect Effects 0.000 claims 1
- 210000002784 stomach Anatomy 0.000 abstract description 20
- 230000000694 effects Effects 0.000 abstract description 14
- 239000003814 drug Substances 0.000 abstract description 13
- 210000000952 spleen Anatomy 0.000 abstract description 11
- 210000000936 intestine Anatomy 0.000 abstract description 10
- 208000024891 symptom Diseases 0.000 abstract description 8
- 238000012360 testing method Methods 0.000 abstract description 8
- 230000007774 longterm Effects 0.000 abstract description 6
- 206010003549 asthenia Diseases 0.000 abstract description 5
- 206010025482 malaise Diseases 0.000 abstract description 4
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 230000006378 damage Effects 0.000 abstract description 3
- 235000019640 taste Nutrition 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 35
- 241001122767 Theaceae Species 0.000 description 34
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 208000031226 Hyperlipidaemia Diseases 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 6
- FQCKMBLVYCEXJB-MNSAWQCASA-L atorvastatin calcium Chemical group [Ca+2].C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1.C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC([O-])=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 FQCKMBLVYCEXJB-MNSAWQCASA-L 0.000 description 5
- 229940002661 lipitor Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000007654 immersion Methods 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000007882 Gastritis Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010030216 Oesophagitis Diseases 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000006881 esophagitis Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241001146155 Emilia Species 0.000 description 1
- 235000019049 Emilia coccinea Nutrition 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000208688 Eucommia Species 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 241001183967 Isodon Species 0.000 description 1
- 244000062241 Kaempferia galanga Species 0.000 description 1
- 235000013421 Kaempferia galanga Nutrition 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000209477 Nymphaeaceae Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 244000153955 Reynoutria sachalinensis Species 0.000 description 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 239000009759 San-Chi Substances 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000015092 herbal tea Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 230000000055 hyoplipidemic effect Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003626 triacylglycerols Chemical group 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to Chinese medicine and field of health care food, more particularly to a kind of reduction blood fat and blood viscosity health beverages.Health beverages of the present invention by lotus leaf, leaves of Hawthorn and six fort tea by raw material is made, preferred liquid beverage, granule and solution tablet.The present invention uses lotus leaf and six fort tea compatibilities, the cold and cool property of lotus leaf is relaxed using the warm nature of six fort tea, so as to mitigate infringement of the lotus leaf to taste, deficiency-cold in spleen and stomach and weak asthenia of qi and blood person is also taken lotus leaf class drink, malaise symptoms will not be produced again while reduction blood fat, blood viscosity and blood pressure.Confirm that health beverages of the present invention have good effect for reducing blood fat, and long-term taking will not cause damage to intestines and stomach through clinical test.
Description
Technical field
The invention belongs to Chinese medicine and field of health care food, more particularly to a kind of reduction blood fat and blood viscosity health beverage
Product.
Background technology
Blood fat is the general name of neutral fat in blood plasma and lipoid, and its main component is triglycerides and cholesterol, works as people
The blood lipid level of body can cause serious harm when too high to health, can such as trigger atherosclerosis, coronary heart disease, pancreatitis many
Plant disease.Blood viscosity is blood viscosity, is one of the key factor to form resistance of blood flow, and blood viscosity is raised can influence micro-
The normal perfusion of circulation, can not only cause the disease such as headache, forgetful, alopecia, insomnia, irregular menstruation, can also promote artery sclerosis, brain
The generation of the major diseases such as infraction, miocardial infarction.In recent years, with the improvement of living standards, high fat diet and amount of exercise subtract
Cause the incidence of disease more and more higher of hyperlipidemia and highly viscous mass formed by blood stasis in crowd less, corresponding, market is for that can drop
The demand of the medicine and health products of low blood fat and blood viscosity is also increasingly urgent.
Lotus leaf is the dried leaf of nymphaeaceae plant lotus (Nelumbo nucifera Gaertn.), bitter, puckery, mild-natured, is returned
Liver, spleen, stomach.Lotus leaf has functions that clearing away summerheat, sending up the lucid yang, dissipate stasis of blood hemostasis, treats the dizziness uncomfortable in chest caused by summer-heat and damp, lets out
Rush down, dysentery, haematemesis, bleeding from five sense organs or subcutaneous tissue, the disease such as uterine bleeding, it can also be used to the treatment of hypertension and hyperlipidemia.However, lotus leaf nature and flavor are cold and cool,
Injuring spleen-stomach, therefore, deficiency-cold in spleen and stomach and weak asthenia of qi and blood person should not take.
Leaves of Hawthorn is rosaceous plant large-fruited Chinese hawthorn (Crataegus pinnatifida Bge.var.major N.E.Br.)
Or the dried leaf of hawthorn (Grataegus pinnati fida Bge.), sour, mild-natured, return liver warp.Leaves of Hawthorn has promoting blood circulationization
The stasis of blood, qi-regulating are promoted blood circulation, change effect of turbid lipid-loweringing, treatment qi depression to blood stasis, chest impediment and cardialgia, chest distress, palpitation and amnesia, dizziness and tinnitus etc.
Disease, is also commonly used for the treatment of hyperlipidemia.However, leaves of Hawthorn is sour, there is certain excitant to intestines and stomach, often taken
May trigger or aggravate the enterogastric diseases such as gastritis, digestive tract ulcer, hyperhydrochloria, esophagitis, therefore, weakness of the spleen and the stomach person is unsuitable
Take leaves of Hawthorn.
Although lotus leaf and leaves of Hawthorn all curative effects with reduction blood fat, its property of medicine greatly limit it and is applicable
Crowd, and, many patients can produce the malaise symptoms of intestines and stomach after the above-mentioned medicinal material of long-term or large dose oral administration.
Six fort tea (Liupao tea), are a kind of black teas with distinguishing character feature for originating from Guangxi Wuzhou.Six fort tea
Belong to warm nature tea, wherein containing various essential amino acids, vitamin, trace element and alcohol element, with clearing heat and promoting diuresis, beneficial spleen
The stagnant, defaecation of disappearing drives dysentery, dissipate the stasis of blood the effects such as promote blood circulation, and refresh the mind, aid digestion, hypotensive, prevent artery sclerosis, radiation proof,
The healthcare functions such as anti-trioxypurine, fat-reducing.Health Products Enterprises have also been developed the guarantor that some are made with six fort tea as primary raw material
Strong drink, for example, application for a patent for invention CN201611129524.6 disclose it is a kind of with wetting one's whistle, the six fort tea of cough-relieving effect,
System is made up of the six fort tea and mangosteen powder, licorice powder that ferment；Patent of invention CN201610175377.X discloses a kind of gut purge
The fort tea of toxin expelling six, is to be made up of Folium Ipomoeae, haw berry, leaves of Hawthorn, six fort tea gross tea and bitter buckwheat；Application for a patent for invention
CN201510242616.4 discloses a kind of six fort tea with strengthen immunity effect, by American ginseng, hawthorn, ganoderma lucidum and fermentation
Six fort tea afterwards are made；Patent of invention CN200910114025.3 discloses one kind and is particularly suitable for " three high one acid " crowd and drinks
Herbal tea, is made up of sanchi flower, tassel flower, galangal, gynostemma pentaphylla, rabdosia lophanthide, spina date seed, the bark of eucommia and six fort tea；Patent of invention Shen
Please CN201510235670.6 disclose it is a kind of contain the composition that six fort tea have hypolipemic function, by six fort tea, giant knotweed, bavin
Recklessly, rheum officinale, hawthorn, cassia seed fleece-flower root are made；Application for a patent for invention CN201510003562.6 discloses a kind of fort of hawthorn six
Tea, is made up, the effect with spleen benefiting and stimulating the appetite, warm stomach nourishing the stomach of six fort tea after hawthorn and fermentation.
In sum, although all had been reported that respectively using the research of lotus leaf, leaves of Hawthorn and six fort tea treatment hyperlipidemias, but
Lotus leaf and six fort tea are applied in combination, the cold and cool property of lotus leaf are relaxed using the warm nature of six fort tea, so as to mitigate lotus leaf to spleen
The infringement of stomach, makes deficiency-cold in spleen and stomach and weak asthenia of qi and blood person also to take lotus leaf class drink, in reduction blood fat, blood viscosity and blood pressure
Malaise symptoms will not be produced again simultaneously, there is not been reported for such research at present.Additionally, in traditional medicine ancient books and records, will not yet
The related record that the two compatibility is used.
The content of the invention
It is of the invention by lotus leaf the invention provides a kind of health beverages by lotus leaf, leaves of Hawthorn and six fort tea prescriptions
Used with six fort tea compatibilities, the cold and cool property of lotus leaf is relaxed using the warm nature of six fort tea, so as to mitigate lotus leaf invade taste
Evil, makes deficiency-cold in spleen and stomach and weak asthenia of qi and blood person also to take lotus leaf class drink, while reduction blood fat, blood viscosity and blood pressure again
Malaise symptoms will not be produced, is confirmed through clinical test, long-term taking health beverages of the present invention can obviously reduce blood lipid,
And intestines and stomach will not be caused damage.
The health beverages of reduction blood fat of the present invention and blood viscosity, it is characterised in that it is by the raw material of following weight parts
It is made：
Lotus leaf 40-45；Leaves of Hawthorn 32-36；Six fort tea 10-13.
The weight portion of above-mentioned raw materials is preferred：
Lotus leaf 40；Leaves of Hawthorn 32；Six fort tea 10.
The weight portion of above-mentioned raw materials is further preferably：
Lotus leaf 42；Leaves of Hawthorn 35；Six fort tea 12.
The weight portion of above-mentioned raw materials is further preferably：
Lotus leaf 45；Leaves of Hawthorn 36；Six fort tea 13.
Further, the health beverages of reduction blood fat of the present invention and blood viscosity, it is characterised in that the health beverages
It is obtained by following step：
Lotus leaf, leaves of Hawthorn and six fort tea are mixed, water rinsing, dry, crush after plus 8-12 times measure water, after immersion 1 hour,
Decoct 1-2 hours, be filtrated to get filtrate, repeat filter residue to decoct 1-2 times under the same conditions, merging filtrate is dispensed after sterilizing
Obtain final product health beverages of the present invention.
Further, the health beverages of reduction blood fat of the present invention and blood viscosity, it is characterised in that the health beverages
It is obtained by following step：
Lotus leaf, leaves of Hawthorn and six fort tea are mixed, water rinsing, dry, crush after plus 8-12 times measure water, after immersion 1 hour,
Decoct 1-2 hours, be filtrated to get filtrate, repeat filter residue to decoct 1-2 times under the same conditions, merging filtrate is concentrated under reduced pressure into
It is spray-dried after small size, is obtained spray dried powder, is then prepared granule or solution according to field of pharmaceutical preparations routine
The method of tablet, is further obtained this health beverages granule or solution tablet.
Moreover, it relates to the health beverages of a kind of reduction blood fat and blood viscosity are preparing Weight-reducing health drink
In application.
Further, the health beverages the invention further relates to a kind of reduction blood fat and blood viscosity are preparing hypotensive guarantor
Application in strong drink.
Further, the health beverages the invention further relates to a kind of reduction blood fat and blood viscosity are preparing bag-soaked health
Application in tea product.
The effects such as health beverages of the present invention have promoting blood circulation and removing blood stasis, reducing blood lipid, reducing blood viscosity, hypotensive, spleen benefiting and stimulating the appetite, suitably
Taken in hyperlipidemia, highly viscous mass formed by blood stasis, Hypertensive Population.
Health beverage formulation of the present invention is simple, and all raw materials are the traditional medicine of integration of drinking and medicinal herbs, and long-term taking safely may be used
Lean on, especially attribute mutually reconciles between each raw material of prescription of the present invention, deficiency-cold in spleen and stomach and weak asthenia of qi and blood person also can normally take,
This health beverages of long-term taking are of great advantage to reduction blood fat and blood viscosity.
Specific embodiment
Embodiments of the present invention are illustrated below by way of specific instantiation, those skilled in the art can be by this specification
Disclosed content understands other advantages of the invention and effect easily.The present invention can also be by specific realities different in addition
The mode of applying is embodied or practiced, the various details in this specification can also based on different viewpoints with application, without departing from
Various modifications or alterations are carried out under spirit of the invention.
Before the specific embodiment of the invention is further described, it should be appreciated that protection scope of the present invention is not limited to down
State specific specific embodiment；It is also understood that the term used in the embodiment of the present invention is specific specific in order to describe
Embodiment, rather than in order to limit the scope of the invention.
When embodiment provides number range, it should be appreciated that except non-invention is otherwise noted, two ends of each number range
Any one numerical value can select between point and two end points.Unless otherwise defined, in the present invention all technologies for using and
Scientific terminology is identical with the meaning that those skilled in the art of the present technique are generally understood that.Except the specific method, equipment used in embodiment,
Outside material, grasp and record of the invention according to those skilled in the art to prior art can also be used and this
Any method, equipment and material in the similar or equivalent prior art of method, equipment described in inventive embodiments, material come real
The existing present invention.
Below in conjunction with specific embodiment and comparative example are to the curative effect of health beverages of the present invention and take security and carry out in detail
Explanation.
Embodiment
A kind of health beverages of reduction blood fat and blood viscosity, this health beverages are made up of the raw material of following weight parts
's：
Lotus leaf 42；Leaves of Hawthorn 35；Six fort tea 12；
Preparation method is as follows：
Lotus leaf, leaves of Hawthorn and six fort tea are mixed, water rinsing, dry, crush after plus 10 times of amount water, after immersion 1 hour, decoct
Boil 1 hour, be filtrated to get filtrate, repeat filter residue to decoct 2 times under the same conditions, merging filtrate, packing obtains final product this after sterilizing
Health beverages.
Comparative example
A kind of health beverages of reduction blood fat and blood viscosity, this health beverages are made up of the raw material of following weight parts
's：
Lotus leaf 42；Leaves of Hawthorn 35；
Preparation method is as follows：
Will lotus leaf and leaves of Hawthorn mix, water rinsing, dry, crush after plus 10 times of amount water, after immersion 1 hour, decoct 1 small
When, filtrate is filtrated to get, filter residue is repeated to decoct 2 times under the same conditions, merging filtrate, packing obtains final product this health beverage after sterilizing
Product.
Clinical test
This test objective is to observe and verify the curative effect of health beverages of the present invention (health beverages in embodiment) and take
Security.
First, case selection and packet
Hyperlipidemia patient 240, is randomly divided into three groups：Positive drug group (Lipitor group), embodiment group (health care of the present invention
Drink) and comparative example group (control group), every group each 80.
Each group age, sex, the course of disease, disease severity, intestines and stomach underlying diseases comparing difference are not statistically significant
(p>0.05)。
2nd, diagnosis basis and inclusive criteria
(1) age requirement 18-65 one full year of life；
(2) Western medicine diagnostic criteria of hyperlipidemia is met；
(3) testing in first 1 month did not carried out other treatment；
(4) without intestines and stomach underlying diseases and other serious organ diseases；
(5) agree to participate in this experiment, and signed Informed Consent Form.
3rd, exclusion standard
(1) age is below 18 one full year of life or 65 one full year of life above persons；
(2) with the enterogastric diseases person such as esophagitis, gastritis, hyperhydrochloria, enteritis, digestive tract ulcer；
(3) gestation and women breast-feeding their children；
(4) there are allergies or allergic constitution person to this health beverages composition；
(5) it is associated with the severe primary disease patient such as cardiovascular and cerebrovascular, liver, kidney, hemopoietic system, internal system；
(6) psychiatric patient.
4th, treatment method
Positive drug group (Lipitor)：Taken medicine according to medicine specification record method, 60 days 1 courses for the treatment of.
Embodiment group：Health beverages of the present invention, 500ml/ days, take, 60 days 1 courses for the treatment of twice sooner or later.
Comparative example group：Comparative example health beverages, 500ml/ days, take, 60 days 1 courses for the treatment of twice sooner or later.
5th, observation index, curative effect and security criterion is taken
Observation index
(1) safety indexes：General physical examination item inspection is carried out before experiment and after being discontinued；Blood, urine, feces routine；The heart, liver,
Kidney function test.
(2) clinical indices：Day by day clinical symptoms, sign change are observed during experiment, and monitors various adverse reactions closely
Time of origin, performance, degree, treatment and result.
Curative effect determinate standard
(1) clinic control：The every inspection in blood fat laboratory recovers normal；
(2) it is effective：Lipids detection reaches following any one person：TC declines >=20% or TG and declines >=40%；
(3) effectively：Lipids detection reaches following any one person：TC decline >=10% but ＜ 20% or TG decline >=20% but
＜ 40%；
(4) it is invalid：Lipids detection is not up to above standard person.
Take security criterion
Count and record each test group occur in process of the test gastrointestinal symptom (including stomachache, diarrhoea, anorexia,
Nausea and vomiting, bitter taste, gasteremphraxis, stomachache, sour regurgitation, belch and other gastrointestinal discomforts) patient's number of cases.
6th, treatment results
After 60 days treat, three groups of clinical efficacies and security statistics is taken referring to table 1 below.
Each test group curative effect of table 1 and take security statistical form
From table 1 it follows that health beverages treatment hyperlipidemia of the present invention, though its total effective rate is lower slightly after taking 60 days
In positive drug Lipitor, but far above control group health beverages, so as to confirm that health beverages of the present invention have to hyperlipidemia
More satisfactory therapeutic effect, and there has also been and significantly carry as its security of pure plant drink and tolerance
Height, additionally, compared with the expensive price of Lipitor, health beverages price of the present invention is relatively low, therefore is easier to be connect by patient
Receive.Comparatively, due to having lacked six fort tea in comparative example group of formula, its treatment total effective rate is significantly lower than embodiment group, from
And illustrate that in this health beverages prescription, six fort tea have very important status, it is former just because of six fort tea and other each tastes
Material synergy so that health beverages of the present invention obtain preferable hyperlipemia therapeutic effect.
Meanwhile, security aspect is taken, harmful effect of the health beverages of the present invention to intestines and stomach is very small, intestines and stomach occurs
Patient's number of cases of symptom illustrates long-term taking health beverages of the present invention right and wrong for intestines and stomach even less than positive drug Lipitor
Chang Anquan's.For comparing, influence of the comparative example group health beverages to intestines and stomach then highly significant, wherein close to the patient of half
Different degrees of gastrointestinal symptom is all occurred in that, this also further demonstrate the reasonability of health beverages prescription of the present invention, therefore,
The applicable crowd of health beverages of the present invention has obtained greatly extending.
The preferred embodiments of the disclosure and embodiment are explained in detail above, but the present invention is not limited to
The above-described embodiment and examples, in the ken that those skilled in the art possess, can also not depart from the present invention
Various changes can be made on the premise of design.
Claims (9)
1. health beverages of a kind of reduction blood fat and blood viscosity, it is characterised in that it is made up of the raw material of following weight parts
's：
Lotus leaf 40-45；Leaves of Hawthorn 32-36；Six fort tea 10-13.
2. health beverages of reduction blood fat as claimed in claim 1 and blood viscosity, wherein the weight portion of each raw material is：
Lotus leaf 40；Leaves of Hawthorn 32；Six fort tea 10.
3. health beverages of reduction blood fat as claimed in claim 1 and blood viscosity, wherein the weight portion of each raw material is：
Lotus leaf 42；Leaves of Hawthorn 35；Six fort tea 12.
4. health beverages of reduction blood fat as claimed in claim 1 and blood viscosity, wherein the weight portion of each raw material is：
Lotus leaf 45；Leaves of Hawthorn 36；Six fort tea 13.
5. reduction blood fat as described in claim any one of 1-4 and the health beverages of blood viscosity, it is characterised in that described
Health beverages are obtained by following step：Lotus leaf, leaves of Hawthorn and six fort tea are mixed, water rinsing, dry, crush after plus 8-12 times
Amount water, after soaking 1 hour, decocts 1-2 hours, is filtrated to get filtrate, repeats filter residue to decoct 1-2 times under the same conditions, closes
And filtrate, packing obtains final product health beverages of the present invention after sterilizing.
6. reduction blood fat as described in claim any one of 1-4 and the health beverages of blood viscosity, it is characterised in that described
Health beverages are obtained by following step：Lotus leaf, leaves of Hawthorn and six fort tea are mixed, water rinsing, dry, crush after plus 8-12 times
Amount water, after soaking 1 hour, decocts 1-2 hours, is filtrated to get filtrate, repeats filter residue to decoct 1-2 times under the same conditions, closes
And filtrate, it is spray-dried after being concentrated under reduced pressure into small size, spray dried powder is obtained, then according to field of pharmaceutical preparations routine
The method for preparing granule or solution tablet, is further obtained this health beverages granule or solution tablet.
7. reduction blood fat and the health beverages of blood viscosity as described in claim any one of 1-4 is preparing Weight-reducing health drink
Application in product.
8. reduction blood fat and the health beverages of blood viscosity as described in claim any one of 1-4 is preparing antihypertensive healthcare
Application in drink.
9. reduction blood fat and the health beverages of blood viscosity as described in claim any one of 1-4 is preparing health-care bagged tea
Application in product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710257896.5A CN106858249A (en) | 2017-04-19 | 2017-04-19 | A kind of health beverages of reduction blood fat and blood viscosity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710257896.5A CN106858249A (en) | 2017-04-19 | 2017-04-19 | A kind of health beverages of reduction blood fat and blood viscosity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106858249A true CN106858249A (en) | 2017-06-20 |
Family
ID=59162717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710257896.5A Pending CN106858249A (en) | 2017-04-19 | 2017-04-19 | A kind of health beverages of reduction blood fat and blood viscosity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106858249A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526263A (en) * | 2011-12-20 | 2012-07-04 | 瑞坝（北京）新能源科技有限公司 | Plant health care product for preventing and treating gout |
| CN102846852A (en) * | 2012-09-29 | 2013-01-02 | 广西梧州制药（集团）股份有限公司 | Composite for lowering blood fat and regulating immunity |
| CN105709102A (en) * | 2016-03-28 | 2016-06-29 | 重庆沐雨健康咨询有限公司 | Herbaceous plant composition for reducing blood fat |
-
2017
- 2017-04-19 CN CN201710257896.5A patent/CN106858249A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102526263A (en) * | 2011-12-20 | 2012-07-04 | 瑞坝（北京）新能源科技有限公司 | Plant health care product for preventing and treating gout |
| CN102846852A (en) * | 2012-09-29 | 2013-01-02 | 广西梧州制药（集团）股份有限公司 | Composite for lowering blood fat and regulating immunity |
| CN105709102A (en) * | 2016-03-28 | 2016-06-29 | 重庆沐雨健康咨询有限公司 | Herbaceous plant composition for reducing blood fat |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102078402B (en) | Traditional Chinese medicine composition for treating hypertension, hyperlipidemia and hyperglycemia | |
| CN107519414A (en) | A kind of composition and preparation method thereof | |
| CN102669667A (en) | Health food with dual functions of protecting liver and adjusting blood fat and preparation method thereof | |
| CN101559186B (en) | Pharmaceutical composition for treating pulmonary tuberculosis, pneumonia and bronchitis | |
| CN101274066B (en) | Chinese medicine composition for tuberculous | |
| CN1935010B (en) | Health food for intensifying body immunological competence and improving memory function, and its preparing method | |
| CN104435837B (en) | A kind of pharmaceutical composition for treating spontaneous perspiration, night sweat | |
| CN102697843B (en) | Health care product for cleaning colon and promoting defecation, and eliminating toxin and beautifying skin and preparation method of same | |
| CN104621310A (en) | Health tea and application thereof | |
| CN106822583A (en) | A kind of regulation blood pressure, blood fat, Chinese medicine composition of blood sugar and preparation method thereof | |
| CN106962698A (en) | A kind of composition, beverage and preparation method thereof | |
| CN103504087A (en) | Pine needle tea drink | |
| CN106858249A (en) | A kind of health beverages of reduction blood fat and blood viscosity | |
| CN108355055A (en) | A kind of pharmaceutical composition for treating hypertension | |
| CN104814432B (en) | A kind of have health-care food composition improving the health care of sleep function and facilitating digestion function and preparation method thereof | |
| CN103735875A (en) | Traditional Chinese medicinal composition for nourishing blood and tonifying qi | |
| CN107440041A (en) | A kind of radix polygonati officinalis honey sauce and preparation method thereof | |
| CN103989817B (en) | A kind of Chinese medicine composition for treating liver-kidney yin deficiency essential hypertension | |
| CN113730504A (en) | A Chinese medicinal composition prepared from multiple medicinal and edible Chinese medicinal materials | |
| CN101411493A (en) | Cold tea for preventing and treating fatigue type sub-health and preparation method thereof | |
| CN111617160A (en) | A Chinese medicinal composition with immunity enhancing effect | |
| CN105267372A (en) | Traditional Chinese medicine granule for treating postoperative gastrointestinal dysfunction and its preparation method | |
| CN105148150A (en) | Healthcare tea and making method thereof | |
| CN100571769C (en) | Granule of zhamusa-four-does and preparation method thereof | |
| CN104435685A (en) | Medicine for treating xerophthalmia and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170620 |
|
| RJ01 | Rejection of invention patent application after publication |